AI-generated summary
This narrative review examines photobiomodulation as a possible treatment for neurodegenerative diseases, summarizing mechanisms and animal studies. The authors report that PBM may curb several disease symptoms and appears less toxic and less invasive than some current therapies. They note that PBM is not yet a mainstream treatment because of unresolved challenges and knowledge gaps.
- Limits stated in the abstract
- The abstract describes a narrative review without a stated number of included studies, and it emphasizes animal studies and unresolved knowledge gaps.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.